New Delhi |ย The National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 year age group, sources said. India’s drug regulator, the Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 last year and […]
Tag: Covovax
Covid vaccine Covovax receives WHO approval for emergency use
New Delhi |ย The World Health Organisation on Friday approved emergency use listing of Covid vaccine Covovax, produced by the Serum Institute of India under licence from Novavax and part of the Covax facility portfolio. “This is yet another milestone in our fight against Covid-19. Covovax is now WHO approved for emergency use, showing excellent safety […]
Covovax for adults in Oct, for children in Jan-Feb: SII CEO Adar Poonawalla
New Delhi |ย The CEO of Serum Institute of India, Adar Poonawala, on Friday expressed hope that another vaccine against Covid-19 being developed by the institue may be launched in October for adults and for children by January-February next year. Poonawala, who met Union Home Minister Amit Shah in the Parliament for 30 minutes on Friday […]
SII begins manufacturing Covovax; to start trial in kids in July
New Delhi |ย The Pune-based Serum Institute of India (SII) has begun manufacturing Novavax’s protein-based vaccine Covovax, CEO Adar Poonawalla has said. The company will also begin clinical trials of Novavax for children starting July. “Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune,” he […]
Serum Institute of India plans to launch Covovax by June: Adar Poonawalla
Pune:ย In what could be a mega boost to the ongoing Covid-19 vaccination drive in India, the Serum Institute of India (SII) has announced its plan to launch its new vaccine, Covovax, by June this year. SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy […]